Platform
Features
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
This company has no offices yet
Solugen
2 followers
Affinia Therapeutics
1 follower
Active Motif
3 followers
Generation Bio
Vaxart
Teach For All
Fortis Life Sciences
CHDI Foundation
5 followers
Helix
9 followers
Cerapedics
Formation Bio
Explore companies